SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month of: October 2014 | Commission File Number: 001-33526 |
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
(Translation of Registrant’s name into English)
545 Promende
du Centropolis
Suite 100
Laval, Québec
Canada H7T 0A3
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ¨ Form 40-F x
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Neptune Technologies & Bioressources Inc. | ||
Date: October 14, 2014 | By: | /s/ André Godin |
Name: | André Godin | |
Title: | Interim Chief Executive Officer |
EXHIBIT INDEX
Exhibit | Description of Exhibit |
99.1 | Neptune MD&A Q2 2015 |
99.2 | Neptune Consolidated Interim Financial Statements Q2 2015 |
99.3 | CEO Certifications – Form 52-109F2 |
99.4 | CFO Certification – Form 52-109F2 |